Entry Point Capital, LLC Essa Pharma Inc. Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding EPIX
# of Institutions
34Shares Held
35.2MCall Options Held
37.7KPut Options Held
3.8K-
Bvf Inc San Francisco, CA8.75MShares$47.1 Million1.41% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.89MShares$42.4 Million0.69% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.21MShares$22.7 Million2.24% of portfolio
-
Morgan Stanley New York, NY4.18MShares$22.5 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.97MShares$16 Million0.8% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $237M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...